FDA approves Moderna's mRNA flu shot for adults 50+, signaling a new vaccine era
TL;DR Summary
The FDA has approved Moderna’s first mRNA-based flu vaccine for adults 50 and over, after an advisory panel’s unanimous vote, with the shot expected to be sold at retailers in coming weeks; the decision comes amid controversy and skepticism from RFK Jr. and expands flu-immunization options.
- A new type of flu shot is coming after FDA approves mRNA-based vaccine The Washington Post
- F.D.A. Approves Moderna’s mRNA Flu Vaccine The New York Times
- FDA Approves First mRNA Flu Vaccine in Win for Moderna After Arduous Process WSJ
- U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech npr.org
- FDA approves first mRNA-based flu vaccine CNN
Reading Insights
Total Reads
1
Unique Readers
4
Time Saved
20 min
vs 21 min read
Condensed
99%
4,076 → 46 words
Want the full story? Read the original article
Read on The Washington Post